Amendment 2025-3111h to HB648 (2025)

Relative to insurance coverage for glucose monitoring.


Revision: Dec. 22, 2025, 11:45 a.m.

Rep. Chourasia, Hills. 11

December 22, 2025

2025-3111h

05/08

 

 

Floor Amendment to HB 648-FN

 

Amend RSA 415:6-e, III(a) as inserted by section 1 of the bill by replacing it with the following:  

 

(a)  Coverage under this paragraph shall be provided without regard to the form of treatment.  Insulin utilization, frequency of administration of insulin, or frequency of blood glucose testing shall not be a requirement for coverage of blood glucose monitoring or CGMS.  Preferred providers or formularies shall include at least 2 of each kind of device.  A prescription shall be required.  Prior authorization may be required.  

 

Amend RSA 415:18-f, III(a) as inserted by section 2 of the bill by replacing it with the following:  

 

(a)  Coverage under this paragraph shall be provided without regard to the form of treatment.  Insulin utilization, frequency of administration of insulin, or frequency of blood glucose testing shall not be a requirement for coverage of blood glucose monitoring or CGMS.  Preferred providers or formularies shall include at least 2 of each kind of device.  A prescription shall be required.  Prior authorization may be required.  

 

Amend RSA 420-A:17-a, III(a) as inserted by section 3 of the bill by replacing it with the following:  

 

(a)  Coverage under this paragraph shall be provided without regard to the form of treatment.  Insulin utilization, frequency of administration of insulin, or frequency of blood glucose testing shall not be a requirement for coverage of blood glucose monitoring or CGMS.  Preferred providers or formularies shall include at least 2 of each kind of device.  A prescription shall be required.  Prior authorization may be required.

 

Amend RSA 420-B:8-k, III(a) as inserted by section 4 of the bill by replacing it with the following:  

 

(a)  Coverage under this paragraph shall be provided without regard to the form of treatment.  Insulin utilization, frequency of administration of insulin, or frequency of blood glucose testing shall not be a requirement for coverage of blood glucose monitoring or CGMS.  Preferred providers or formularies shall include at least 2 of each kind of device.  A prescription shall be required.  Prior authorization may be required.

 

Amend the bill by replacing section 5 with the following:  

 

5  Effective Date.  This act shall take effect July 1, 2027.